Kevin Joseph Fitzgerald is a corporate insider at Ovid Therapeutics Inc. (OVID). Fitzgerald's filing history also covers ALNYLAM PHARMACEUTICALS, INC. (ALNY). Fitzgerald has reported 12 insider filings with the SEC since 2024. The most recent filing was in April 2026.
Every role Kevin Joseph Fitzgerald has reported on a Form 4, reconstructed from the filings themselves. Reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
Updated Aug 31, 2026
Kevin Joseph Fitzgerald files SEC Form 4 reports at Ovid Therapeutics Inc. (OVID). 12 SEC Form 4 filings on record going back to 2024, most recently on 9 April 2026. Most recent open-market trade: sold $50K of ALNY on 6 March 2026. Lifetime open-market sales: $10.73M.
Every recent SEC Form 4 transaction Kevin Joseph Fitzgerald has reported, most recent first.
InsiderAlpha's records for Kevin Joseph Fitzgerald go back to 2024: 12 primary Form 4 filings, an average of 4.0 per year. 54 recorded transactions carry a Rule 10b5-1 flag, meaning they were pre-scheduled under a written trading plan rather than discretionary.
Insiders who reported open-market trades in the last 12 months at the companies Kevin Joseph Fitzgerald files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Kevin Joseph Fitzgerald is a corporate insider of Ovid Therapeutics Inc. (OVID). InsiderAlpha holds 12 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
The most recent primary Form 4 on record is dated 9 April 2026, one of 12 filings going back to 2024.
Recorded transactions: 0 open-market purchases and 68 open-market sales ($10.73M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial